Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
CureDuchenne Ventures Invests in TRiNDS to Provide Clinical Trial Solutions for Neuromuscular Disorders
Tuesday, December 20, 2016CureDuchenne Ventures LLC a company that funds research to find a cure for Duchenne muscular dystrophy announced today that they invested in TRiNDS LLC a new contract research organization born from the Cooperative International Neuromuscular Researc...
Aurinia Pharmaceuticals Entered into Manufacturing Collaboration Agreement with Lonza for Voclosporin
Tuesday, December 20, 2016Aurinia Pharmaceuticals Inc a clinical stage biopharmaceutical company focused on the global immunology market today announced it has entered into a longterm agreement with Lonza for the manufacture of voclosporin active pharmaceutical ingredient API...
RegeneRx Receives Notice of Intent to Grant Patent in EU for Treating Neural Injury with Thymosin Beta 4
Monday, December 19, 2016RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration today announced that it has received notice of Intent to Grant a patent from the European Patent Office for treating neural...
Ionis Pharmaceuticals Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer
Monday, December 19, 2016Ionis Pharmaceuticals Inc announced that it has earned million from AstraZeneca following AstraZenecas completion of INDsupporting studies and license of IONISKRASRx or AZD IONISKRASRx is a Generation antisense drug discovered by Ionis designed to...
bluebird bio and apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement
Friday, December 16, 2016bluebird bio Inc a clinicalstage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cellbased immunotherapies for cancer and apceth Biopharma GmbH wwwapcethcom the global innovator and leader i...
Baxter International to acquire Claris Injectables Limited for $625 Million
Friday, December 16, 2016Baxter International Inc a global leader in sterile medication production and delivery today entered into a definitive agreement to acquire Claris Injectables Limited a wholly owned subsidiary of Claris Lifesciences Limited for total consideration of...
Evotec and Celgene enter into drug discovery collaboration for neurodegenerative diseases
Friday, December 16, 2016Evotec AG announced that Evotec and Celgene Corporation have entered into a strategic drug discovery and development collaboration to identify diseasemodifying therapeutics for a broad range of neurodegenerative diseases Initial disease areas of focu...
IntelGenx and RedHill Biopharma Signed License Agreement with Pharmatronic Co.
Thursday, December 15, 2016IntelGenx Corp and RedHill Biopharma Ltd announced the signing of an exclusive license agreement with Pharmatronic Co Pharmatronic Co for the commercialization of RIZAPORT in the Republic of Korea South Korea RIZAPORT is a proprietary oral thin film...
CFDA Granted Approval for Phase I/II/III Clinical Trials of Sihuan Pharmaceutical’s Fadanafil Drug
Thursday, December 15, 2016Sihuan Pharmaceutical Holdings Group Ltd a leading pharmaceutical company with the largest cardiocerebral vascular drug franchise in Chinas prescription market announced that the China Food and Drug Administration CFDA has granted approval of Phase I...
Ab Initio Announces Collaboration Agreement with Pfizer to Discover GPCR Activating Antibodies
Wednesday, December 14, 2016Ab Initio Biotherapeutics Inc today announced a collaborative research and license agreement with Pfizer Inc NYSE PFE that aims to discover novel therapeutic antibodies against an undisclosed target in the Gprotein coupled receptor GPCR superfamily G...
